Catalyst Health Stock Hits New 52-Week High (CHSI)

NEW YORK ( TheStreet) -- Catalyst Health Solutions (Nasdaq: CHSI) hit a new 52-week high Thursday as it is currently trading at $85.43, above its previous 52-week high of $85.30 with 545,494 shares traded as of 10:05 a.m. ET. Average volume has been 302,200 shares over the past 30 days.

Catalyst Health has a market cap of $3.13 billion and is part of the financial sector and insurance industry. Shares are up 63.9% year to date as of the close of trading on Wednesday.

Catalyst Health Solutions, Inc. operates as a full-service pharmacy benefit management company primarily under the Catalyst Rx name in the United States. The company has a P/E ratio of 45.7, above the average insurance industry P/E ratio of 44.8 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Catalyst Health as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Catalyst Health Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.